46 results about "Rubia" patented technology

A staltic Chinese medicine in the form of oral liquid for treating the abnormal metrorrhagia is prepared from 20 Chinese-medicinal materials including cuttlefish bone, madder, astragalus root, Chinese angelica root, etc. Its advantage is high curative effect.

The present invention relates to an ostrich oil and Chinese Tibetan medicine ointment for effectively using wound, burn and scald and its preparation method. Said invention includes the following components: 81g of dried rhizome of paris polyphylla, 81g of rubia root, 81g of Chinese angelica root, 100g of sanguisorba root, 150g of flavescent sophora root, 85g of rhubarb, 100g of phellodendron bark, 90g of giant knotweed rhizome and ostrich oil, the weight ratio of ostrich oil and above-mentioned all the Chinese Tibetan medicines extract is 2.5:1. Its preparation method includes the following steps: dissolving ostrich oil at 80deg.C, progressively adding the Chinese Tibetan medicines extract broken to 120 meshes into the dissolved ostrich oil according to the mixing ratio of 2.5:1, then adding small quantity of paraffin wax, quickly stirring them, uniformly mixing them, disinfecting and filling so as to obtain the invented finished product.

The invention relates to a traditional Chinese medicine for treating breast hyperplasia and breast cancer. The traditional Chinese medicine can be used for effectively solving the treatment medicinal problems of the breast hyperplasia and breast cancer. The technical scheme for solving the problems is as follows: the traditional Chinese medicine is prepared from radix curcumae processed with vinegar, trigone processed with vinegar, rhizoma zedoariae processed with vinegar, processed pangolin, seaweed, iphigenia indica, radix codonopsitis, astragalus root, fruit of glossy privet, honeysuckle, lithospermum, chrysanthemum, rhizoma cyper processed with vinegar, trichosanthes, rubia root, corydalis tuber processed with vinegar, uniflower swisscentaury root, rhizoma coptidis, processed vomiting nut, chilopod, rheum officinale, fried cowherb seed, fried mustard seed, tangerine seed, prepared frankincense, prepared myrrh, oarweed and paris polyphylla. The material medicines are crushed and prepared into pills by using water and dried, respectively. The material medicines are effectively combined and supported with each other to achieve the effects of detoxicating and resolving a mass, tonifying qi and dredging collaterals, and promoting blood circulation to remove blood stasis. Besides, the traditional Chinese medicine is effectively used for treating the breast hyperplasia and breast cancer, and is safe in medicine use, good in curative effect and innovative on medicines for treating the breast hyperplasia and breast cancer.

The invention discloses dammarane triterpenoid glycoside compounds as well as a preparation method and application thereof. The dammarane triterpenoid glycoside compounds are specifically three compounds which are separated from a rubiaceae rubia plant, namely Mycephala sinensis (Hemsl.) Craib, and the structural formula of the dammarane triterpenoid glycoside compounds is shown in the specification. Tests show that the dammarane type triterpenoid saponin with the structure shown in the formula 2 has sweetness, the sweetness of the dammarane type triterpenoid saponin is about 200 times that ofcane sugar, and the dammarane type triterpenoid saponin can be used as a sweetening agent and applied to various industries such as food and medicines.

The invention provides a traditional Chinese medicine composition for treating and regulating dysmenorrhea, which comprises the following traditional Chinese medicine raw materials: common bluebeard herb, dragon's blood resin, fluorite, eucommia bark, suakwa vegetable sponge, cassia, motherwort, folium citri reticulatae, rubia root, burreed rhizome, dandehon herb, flower of lilac daphne, xiaohongteng, rhizome of Chinese ligusticum, corydalis tuber, ricepaper pith, prunella spike, areca seed, fenugreek seed, ledebouriella root, dodder seed, achyranthes root, toosendan fruit, asarum herb, loranthus, cynomorium and myrrh. The traditional Chinese medicine composition is prepared after repeated validation of clinical tests, conforms to the traditional Chinese medical theories, and has the effects of activating blood, dissolving stasis, removing blood stasis, dissipating masses, soothing the liver, regulating qi, relieving pain, dredging the channels and collaterals, supplementing qi and promoting the secretion of saliva or body fluid; the traditional Chinese medicine composition is prepared according to an ancestral secret recipe and years of treatment experiences, exerts the functions of nourishing blood, regulating menstruation, dispelling cold, activating qi, clearing and activating the channels and collaterals, regulating qi and blood and clearing damp-heat, can be acted at the lesions and uterine cavity, and has good curative effect for treating the patients with dysmenorrhea and irregular menstruation; and the regularity in menstrual period is adjusted under the progressive action of the medicament, and the menstruation disorder gradually returns to normality.

The insecticide of the present invention comprises at least one member selected from a plant, an extract of the plant, and an ooze (or exudate) of the plant, wherein the plant belongs to at least one genus selected from the group consisting of the genus Geranium, the genus Morus, the genus Artemisia, the genus Diospyros, the genus Crataegus, the genus Curcuma, the genus Rubia, the genus Polygonum, the genus Gardenia, the genus Cornus, the genus Uncaria, the genus Rheum, the genus Terminalia and the genus Saussurea. The extract may be a substance extracted with at least one member selected from the group consisting of water and a hydrophilic solvent. The insecticide exhibits high insecticidal and insect-controlling activity against insects (e.g., sanitarily injurious insects, insects injurious to houses and particularly to timber such as termites), being highly safe to human beings and animals and not adversely affecting the environment.

The invention discloses a naphthoquinone dimer separated from Rubia plant, a pharmaceutical composition taking the naphthoquinone dimer as an active ingredient, an Nf-kB signal pathway inhibitor taking the naphthoquinone dimer as an active ingredient, a preparation method, and applications of the naphthoquinone dimer in drugs for treatment and prevention of related inflammatory diseases and cancers activated by abnormality of an Nf-kB signal pathway, belonging to the technical field of pharmaceuticals. The Rubioncolin C (1) is a naphthoquinone dimer separated from Rubiapodantha D., and has in vitro and vivo anti-tumor and Nf-kB signal pathway inhibition activity. The naphthoquinone dimer can be applied in preparation of anti-tumor pharmaceutical preparation and precursor drugs, and has the advantages of being low in preparation cost, low in toxicity, good in anti-tumor effect, and the like.

The invention discloses a herbal medicament for treating piglet white scour. The herbal medicine is prepared from Cierbao, lily and rubia root. A liquid medicament is obtained with a water decoction method. The herbal medicament is mixed with a feed for feeding a sow two weeks before delivery of the sow, so that a prevention effect can be achieved; and the liquid medicament is fixed into feed for feeding the sow after the delivery of piglets and before white scour occurs, so that piglet white scour can be prevented, and can be healed by increasing the medicament amount after occurrence.

The invention discloses a Radix rubiae cyclic peptide compound and a preparation method thereof. The preparation method of the Radix rubiae cyclic peptide compound comprises the following steps: usingstems and/or leaves of Rubia hangii as raw materials, obtaining an extract of the Rubia hangii, and separating and purifying the obtained extract through a macroporous resin column, a silica gel column and a high-speed counter-current chromatograph to obtain the Radix rubiae cyclic peptide compound. Experiment results of the applicant show that the compound has strong binding capacity with coronavirus targets (S protein, 3CL protein, DC-SIGN receptor protein and ACE2 receptor protein), HIV targets (HIV-1 protein) and hepatitis B virus targets (Bcl-2, Bcl-xL), so the component has potential medicinal value for novel coronaviruses, HIV viruses and hepatitis B viruses. The compound is expected to be used for preparing anti-coronavirus drugs and/or anti-HIV and/or anti-hepatitis B virus drugs.

The invention relates to medicine for fast treating inflammatory demyelinating polyneuropathy. The medicine is prepared from the following ingredients in parts by weight: 9 to 14 parts of oryzanol, 6 to 11 parts of clematis chinensis, 5 to 10 parts of radix paeoniae alba, 6 to 12 parts of ligusticum chuanxiong hort, 4 to 11 parts of scorpio, 5 to 10 parts of earthworms, 6 to 9 parts of asarum sieboldii, 5 to 8 parts of claoxylon indicum hassk, 5 to 11 parts of spilanthes paniculata, 6 to 12 parts of rubia kaematantha airy-shaw, 5 to 10 parts of phellodendron amurense, 5 to 10 parts of conical redpepper fruit, 6 to 11 parts of melodinus suaveolens, 5 to 12 parts of cynomorium songaricum, 5 to 10 parts of boxthorn roots, 6 to 11 parts of eucommia ulmoides oliver, 5 to 10 parts of magnolia officinalis, 4 to 8 parts of semen euphorbiae lathyridis and 5 to 9 parts of solidago canadensis. The medicine has a good treatment effect on the inflammatory demyelinating polyneuropathy.

The invention relates to an agentia for treating blood-stasis type non-stop lochia after delivery. The agentia is prepared by the following substances in parts by weight: 1-10 parts of assorted Chinese herbal tea, 1-10 parts of cirsium japonicum, 10-20 parts of radix pittospori, 10-20 parts of Chinese alpine rush, 1-10 parts of radix rubiae, 1-10 parts of tangerine pith, 15-30 parts of sporobolus fertilis, 10-20 parts of rubia membranacea root, 1-10 parts of silkworm larva, 1-10 parts of euonymus porphyreus, 5-15 parts of panax japonicus, 1-10 parts of radix cyathulae, 10-20 parts of potentilla bifurca, 1-10 parts of resina liquidamberis, 10-20 parts of orixa japonica, 10-20 parts of bermuda grass, 5-15 parts of herba lycopi, 1-10 parts of persimmon bark, 1-10 parts of cattail roots, 10-20 parts of oil tea camellia leaves, 1-10 parts of liquorice and 10-20 parts of ginkgo roots. The agentia has the main functions of activating blood and dispersing blood stasis and cooling blood and removing blood stagnation, also has the auxiliary functions of benefiting qi and generating blood, clearing heat and removing toxicity and nourishing kidney and yin, has obvious effect for treating the blood-stasis type non-stop lochia after delivery and is worthy of being promoted clinically.

The Chinese medicine composite zuanshanfeng dripping pills preparation for curing the diseases of cold pain in the lumbus and knees, numbness of the limbs and inhibited bending and stretching resulted from arthralgia due to wind-cold-dampress is made up by using extract of 7 Chinese medicinal materials of zuanshanfeng. berchemia sinica, rubia maillardi, clematis root, moghania root, millettia hirsutissima and alpinia japonica as raw material and pharmaceutical aueptable carrier through a certain preparation process.

The invention discloses a traditional Chinese medicine composition mainly for treating uremia. The composition is mainly prepared from, by mass, 9-13 parts of plantain herbs, 7-12 parts of selaginella nipponica, 6-11 parts of white ground elm, 8-14 parts of malva crispa leaves, 6-10 parts of lily, 5-9 parts of rubia yunnaensis, 7-13 parts of magnoliopsida verbenaceae, 10-14 parts of scouring rush, 8-15 parts of dandelion, 6-12 parts of phyllanthus urinaria, 9-14 parts of stellaria yunnanensis, 7-11 parts of litsea cupularis hemsl, 8-13 parts of creeping oxalis and 6-10 parts of aeschynomene indica. The composition is formed according to many years of clinical practice summary, has the effects of clearing heat, promoting diuresis, detoxicating and treating stranguria, and is remarkable in curative effect.

The invention discloses a traditional Chinese medicine decoction for treating thrombocytopenia. The traditional Chinese medicine decoction comprises the following raw materials in parts by weight: 5.5-6.5 parts of dried rehmannia root, 6-7 parts of astragalus root, 2-4 parts of glossy privet fruit, 6-8 parts of spatholobus stem, 2-4 parts of notoginseng, 1-3 parts of muskmelon skin, 6-8 parts of carbonized sanguisorba root, 4-6 parts of radix codonopsis pilosulae, 2-4 parts of black sesame seed, 4-6 parts of common dodder, 1-3 parts of giant knotweed rhizome, 6-8 parts of semen litchi, 2-4 parts of pteridium squilinum, 1-3 parts of rubia root, 5-7 parts of cortex lycii radicis, 3-5 parts of cordyceps sinensis, 2-4 parts of tuckahoe, 5-7 parts of rhizoma polygonati, 1-3 parts of purpleflower holly bark, 2-4 parts of doellingeria scaber root, 2-4 parts of clinopodium chinense, 1-3 parts of black soybean leaf and 4-6 parts of drymaria cordata. The Chinese medicinal composition disclosed by the invention has effects on clearing away heat and toxic materials, cooling blood to remove stasis, invigorating qi, nourishing Yin and tonifying the kidneys, is quick and effective in treating thrombocytopenia, high in cure rate and low in recurrence rate, does not have any toxic or side effects, and can improve human immunity and improve the physical quality of patients.

The present invention pertains to a herbal formulation with highly potent wound healing properties, in humans and animals. The composition consists of aqueous extracts of Azadirachta indica, in a mixture of natural oils along with herbs viz. Berberis aristata, Curcuma longa, Glycyrrhiza glabra, Jasminum officinale, Picrorhiza kurrooa, Pongamia pinnata, Rubia folia, Saussurea lappa, Terminalia chebula, Trichosanthes dioica, Capsicum and Stellata wild in well-defined ratios. The invention also includes a process for preparing the formulation by extracting the water-soluble components from bark of Azadirachta indica.

The invention provides a traditional Chinese medicine for treating spleen insufficiency damp-heat type colpitis mycotica and a preparation method of the traditional Chinese medicine. The traditional Chinese medicine comprises the following raw material medicines: rubia membranacea, psidium guajave leaves, rumexjaponicus leaves, aleuritopteris farinose, winkled marshweed, manglietia insignis, lobaria isidiosa, odontites vulgaris, lythrum salicaria, oxygraphis glacialis, viburnum macrocephalum stems, Japanese plum root bark, euphorbia lunulata, kirilow groundsel herb and asparagus gobicus. The traditional Chinese medicine has a definite treatment effect on spleen insufficiency type colpitis mycotica and is small in toxic and side effects and short in treatment course, and the disease is difficult to reoccur.

The invention relates to a traditional Chinese medicine for treating hyperostosis, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine moxibustion composition comprises rhizome of Chuanxiong, rhizoma corydalis, frankincense, myrrh, safflower carthamus, China rose, mulberry twig, caulis sinomenii, dried body of ground beetle, logwood, rhizoma drynariae, common clubmoss herb, large-leaved gentian, Chinese angelica, caulis spatholobi, rubia, forsythia, glabrous greenbrier rhizome, mature vinegar and wine. By the aid of the traditional Chinese medicine, the hyperostosis is remarkably treated, and the healed hyperostosis cannot recur.